Ed Margerrison, Ph.D.
Director
Office of Science and Engineering
Federal Drug Administration
Ed has recently joined FDA as the Office Director for the Office of Science and Engineering Laboratories, who are responsible for providing technical expertise and analyses in support of the regulatory processes within the Center for Devices and Radiological Health. Prior to this appointment, he was President and CEO of Ortho Regenerative Technologies, a biotech startup based Montreal, developing novel biomaterial approaches to surgical soft tissue repair. He has also held senior positions at Zimmer Biomet (Vice President of Biologics), Akela Pharma (VP Program Management) and Smith & Nephew plc (Director of Research). He graduated in Biochemistry from the University of Oxford and gained his PhD in Molecular Genetics from St George’s Hospital Medical School in London UK.